August 2025, Volume 2, No. 8
Table of Contents

Letter from the Editors

Free article

Atrial septal occlusion devices are used to close abnormal holes between the upper chambers of the heart and remain a core intervention in congenital cardiology. Driven by a stable rate of atrial septal defects (ASDs) per birth and evolving closure device technology, the ASD occluder market is experiencing steady growth.

Free article

From humble beginnings in rural Indiana to advising billion‑dollar global impact initiatives, and now leading a company looking to reshape surgical practice, Gabriel Jones is redefining how we see and trust surgery. As CEO and co-founder of Proprio, Jones is forging a platform that blends real‑time, light-field imaging with artificial intelligence to shift the odds in the operating room and in people’s lives.

Free article

With a $1.1B exit and decades of hard-won lessons under his belt, Corindus co-founder Tal Wenderow is back in the trenches. This time, he’s building momentum and star power as a hands-on investor with his new firm, Star51 Capital, that is on an urgent, non-traditional mission to align incentives across key stakeholders, support founders, and reshape healthcare from the ground up.

Need fresh inspiration for your medtech company as we navigate Q325? We’ve gathered insights from some of our LSI alumni thought leaders to help you stay ahead.

Celebrating recent leadership shifts and other announcements and accolades impacting our global LSI Alumni medtech community.

Select Medtech Industry Financings & Deals: July 2025, by Date Announced

Femoral closure devices play a critical role in achieving hemostasis following catheter-based cardiovascular and endovascular procedures requiring femoral artery access. This category includes active devices such as clips, plugs, and sutures, as well as passive devices that apply pressure to support coagulation as an alternative to manual compression. Despite headwinds from the growing use of radial artery access, the market is showing low single-digit revenue growth through 2029, driven by innovation, large-bore procedures, and incremental pricing increases.

Every week, LSI’s Market Intelligence team tracks key shifts, deals, and signals shaping global medtech. In July, our coverage included Q2 investment activity, the evolving surgical robotics landscape, a landmark diagnostics merger, and Q2 earnings reports from the sector’s top players. From boardroom strategy to operating room innovation, here’s what moved the needle.

Select Femoral Access Procedure Volumes, by Region, 2023–2030

Select Congenital Heart Disease Procedures: Global, U.S., Germany, and Japan, 2023-2030

Arsenal Medical isn’t just developing new products; it’s challenging foundational assumptions about how medical devices should be created. Led by President and CEO Dr. Upma Sharma, Arsenal is reimagining the role of biomaterials in medicine, designing them from the molecule up to meet overlooked and underserved clinical needs.

Celebrating the accomplishments of a few of the many bright stars in our LSI presenting company and speaker alumni community.

This month we’re showcasing technologies and organizations impacting our industry, and patient lives.

Trusted By The Companies Pioneering What’s Next

Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.